Vaxcyte (PCVX) Short Interest Ratio & Short Volume $35.32 -0.52 (-1.45%) Closing price 03:59 PM EasternExtended Trading$35.70 +0.38 (+1.07%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Vaxcyte Short Interest DataVaxcyte (PCVX) has a short interest of 12.34 million shares, representing 10.22% of the float (the number of shares available for trading by the public). This marks a 2.41% increase in short interest from the previous month. The short interest ratio (days to cover) is 6.3, indicating that it would take 6.3 days of the average trading volume of 1.25 million shares to cover all short positions.Current Short Interest12,340,000 sharesPrevious Short Interest12,050,000 sharesChange Vs. Previous Month+2.41%Dollar Volume Sold Short$373.04 millionShort Interest Ratio6.3 Days to CoverLast Record DateApril 15, 2025Outstanding Shares128,939,000 sharesShort Percent of Float10.22%Today's Trading Volume3,175,649 sharesAverage Trading Volume1,253,371 sharesToday's Volume Vs. Average253% Short Selling Vaxcyte? Sign up to receive the latest short interest report for Vaxcyte and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPCVX Short Interest Over TimePCVX Days to Cover Over TimePCVX Percentage of Float Shorted Over Time Vaxcyte Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202512,340,000 shares $373.04 million +2.4%10.2%6.3 $30.23 3/31/202512,050,000 shares $455.01 million -4.4%10.0%6.6 $37.76 3/15/202512,610,000 shares $937.81 million +2.3%10.4%10.9 $74.37 2/28/202512,330,000 shares $900.34 million -7.5%10.2%10.7 $73.02 2/15/202513,330,000 shares $1.12 billion -1.5%11.0%12 $84.00 1/31/202513,530,000 shares $1.19 billion -6.6%N/A10.3 $88.32 1/15/202514,490,000 shares $1.29 billion +1.2%N/A11.4 $89.29 12/31/202414,320,000 shares $1.17 billion +13.7%N/A12.7 $81.86 12/15/202412,600,000 shares $1.11 billion +14.2%N/A11.4 $87.72 11/30/202411,030,000 shares $1.04 billion +13.8%N/A10.4 $94.34 Get the Latest News and Ratings for PCVX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vaxcyte and its competitors with MarketBeat's FREE daily newsletter. 11/15/20249,690,000 shares $841.38 million +8.5%N/A7.6 $86.83 10/31/20248,930,000 shares $949.71 million -4.4%N/A9.2 $106.35 10/15/20249,340,000 shares $1.08 billion -3.2%N/A10.2 $115.49 9/30/20249,650,000 shares $1.10 billion -0.6%N/A10 $114.27 9/15/20249,710,000 shares $1.13 billion -5.7%N/A9.4 $116.00 8/31/202410,300,000 shares $831.83 million -8.4%N/A10.4 $80.76 8/15/202411,240,000 shares $881.67 million -2.3%N/A15.9 $78.44 7/31/202411,500,000 shares $907.24 million -3.1%N/A15.4 $78.89 7/15/202411,870,000 shares $999.10 million +15.5%N/A16.2 $84.17 6/30/202410,280,000 shares $776.24 million +6.2%N/A14.6 $75.51 6/15/20249,680,500 shares $706.10 million +0.8%N/A14.9 $72.94 5/31/20249,600,000 shares $674.59 million +0.8%N/A15.3 $70.27 5/15/20249,520,000 shares $681.92 million +12.9%N/A13.7 $71.63 4/30/20248,430,000 shares $510.44 million +2.3%N/A11.7 $60.55 4/15/20248,240,000 shares $514.09 million -0.2%N/A9.7 $62.39 3/31/20248,260,000 shares $564.24 million -3.8%N/A9.6 $68.31 3/15/20248,590,000 shares $598.72 million +1.5%N/A9.9 $69.70 2/29/20248,460,000 shares $624.52 million -20.6%N/A9.3 $73.82 2/15/202410,650,000 shares $798.86 million +19.7%N/A12.3 $75.01 1/31/20248,900,000 shares $635.64 million +6.5%N/A10.7 $71.42 1/15/20248,360,000 shares $507.62 million +9.7%N/A12.4 $60.72 12/31/20237,620,000 shares $478.54 million +3.7%N/A11.6 $62.80 12/15/20237,350,000 shares $445.12 million +3.8%N/A11.6 $60.56 11/30/20237,080,000 shares $366.53 million -2.6%N/A11.5 $51.77 11/15/20237,270,000 shares $369.32 million -0.8%N/A12.6 $50.80 10/31/20237,330,000 shares $352.57 million +6.2%N/A12.7 $48.10 10/15/20236,900,000 shares $317.40 million -4.2%N/A12.8 $46.00 9/30/20237,200,000 shares $367.06 million -9.1%N/A13.5 $50.98 9/15/20237,920,000 shares $409.62 million +4.9%N/A14.9 $51.72 8/31/20237,550,000 shares $392.00 million -2.6%N/A13.9 $51.92Watch This Robotics Demo Before July 23rd (Ad)Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo… 8/15/20237,750,000 shares $368.05 million +3.6%N/A13.6 $47.49 7/31/20237,480,000 shares $359.49 million -0.1%N/A12.3 $48.06 7/15/20237,490,000 shares $371.80 million +0.4%N/A10.2 $49.64 6/30/20237,460,000 shares $372.55 million +8.4%N/A8.1 $49.94 6/15/20236,880,000 shares $358.72 million -2.7%N/A7.2 $52.14 5/31/20237,070,000 shares $350.11 million +4.0%N/A7.5 $49.52 5/15/20236,800,000 shares $342.45 million +3.8%N/A7 $50.36 4/30/20236,550,000 shares $280.54 million -7.1%N/A7 $42.83 4/15/20237,050,000 shares $257.33 million +17.3%N/A8.1 $36.50 3/31/20236,010,000 shares $225.25 million +6.0%N/A8.8 $37.48 3/15/20235,670,000 shares $220.56 million +14.8%N/A8.3 $38.90 2/28/20234,940,000 shares $202.39 million +4.7%N/A7 $40.97 2/15/20234,720,000 shares $203.67 million +1.5%N/A6.6 $43.15 1/31/20234,650,000 shares $210.88 million +5.9%N/A6 $45.35 1/15/20234,390,000 shares $195.88 million -2.0%N/A3.3 $44.62 12/30/20224,480,000 shares $214.82 million +30.2%N/A3.4 $47.95 12/15/20223,440,000 shares $156.45 million +3.6%N/A2.6 $45.48 11/30/20223,320,000 shares $152.92 million -8.8%N/A2.7 $46.06 11/15/20223,640,000 shares $160.31 million -12.3%N/A3.1 $44.04 10/31/20224,150,000 shares $180.98 million +29.7%N/A3.7 $43.61 10/15/20223,200,000 shares $78.59 million +29.0%8.2%4.2 $24.56 9/30/20222,480,000 shares $59.52 million +22.8%6.3%5.7 $24.00 9/15/20222,020,000 shares $57.00 million +10.4%5.2%5.1 $28.22 8/31/20221,830,000 shares $47.87 million -12.9%4.7%4.8 $26.16 8/15/20222,100,000 shares $54.68 million +4.5%5.4%5.5 $26.04 7/31/20222,010,000 shares $46.39 million -1.0%5.3%5.4 $23.08 7/15/20222,030,000 shares $50.53 million +9.7%5.4%5.6 $24.89 6/30/20221,850,000 shares $40.26 million +11.5%4.9%5 $21.76 6/15/20221,660,000 shares $31.04 million -18.2%4.4%4.4 $18.70 5/31/20222,030,000 shares $48.70 million +2.0%5.4%6.3 $23.99 5/15/20221,990,000 shares $46.82 million +4.2%5.3%7 $23.53 4/30/20221,910,000 shares $46.24 million +2.7%5.2%6.9 $24.21 4/15/20221,860,000 shares $45.63 million -6.5%5.0%6.6 $24.53 3/31/20221,990,000 shares $48.06 million -0.5%5.6%6.3 $24.15 3/15/20222,000,000 shares $49.78 million -1.5%5.6%6.9 $24.89 2/28/20222,030,000 shares $47.04 million +9.7%5.7%7 $23.17 2/15/20221,850,000 shares $38.31 million +12.8%5.3%6.4 $20.71 1/31/20221,640,000 shares $31.23 million +28.1%5.1%6.2 $19.04 1/15/20221,280,000 shares $24.87 million +14.3%4.0%5.5 $19.43 12/31/20211,120,000 shares $26.64 million -21.7%3.7%7 $23.79 12/15/20211,430,000 shares $32.02 million +26.6%4.7%9.5 $22.39 11/30/20211,130,000 shares $23.03 million -7.4%3.8%7.5 $20.38 11/15/20211,220,000 shares $31.82 million -6.9%4.1%8.1 $26.08 10/29/20211,310,000 shares $30.65 million +2.3%4.5%8 $23.40 10/15/20211,280,000 shares $31.24 million -9.9%4.3%7.8 $24.41 9/30/20211,420,000 shares $36.03 million -20.7%4.8%8.4 $25.37 9/15/20211,790,000 shares $47.35 million -23.5%6.1%9 $26.45 8/31/20212,340,000 shares $61.38 million -17.6%8.0%11.2 $26.23 8/13/20212,840,000 shares $73.93 million +1.8%9.8%13.2 $26.03 7/30/20212,790,000 shares $60.49 million -6.4%9.8%13.1 $21.68What President Trump’s Executive Order 14154 means for your money (Ad)Nearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a former hedge fund manager who predicted the dotcom crash, the housing crisis, and the 2022 tech stock bloodbath - a little-known executive order from the President's first day in office could spark a paradigm-shift that will likely catch millions of Americans off guard.But because of the massive changes impacting U.S. stocks, Tilson has agreed to publish his latest fi 7/15/20212,980,000 shares $61.06 million -2.9%10.2%13.3 $20.49 6/30/20213,070,000 shares $69.11 million -13.0%10.5%12.5 $22.51 6/15/20213,530,000 shares $77.94 million -1.1%12.1%13.3 $22.08 5/28/20213,570,000 shares $75.22 million -4.3%12.2%11.4 $21.07 5/14/20213,730,000 shares $71.21 million No Change12.8%10.8 $19.09 4/30/20213,730,000 shares $69.97 million -1.1%13.2%9.1 $18.76 4/15/20213,770,000 shares $75.02 million -21.1%13.3%9 $19.90 3/31/20214,780,000 shares $89.19 million +27.1%17.0%11.3 $18.66 3/15/20213,760,000 shares $99.19 million -0.5%13.5%9 $26.38 2/26/20213,780,000 shares $95.26 million +12.5%13.6%10.2 $25.20 2/12/20213,360,000 shares $86.89 million +3.7%12.1%9.1 $25.86 1/29/20213,240,000 shares $78.15 million +6.2%11.1%10 $24.12 1/15/20213,050,000 shares $78.78 million No Change10.5%11 $25.83 PCVX Short Interest - Frequently Asked Questions What is Vaxcyte's current short interest? Short interest is the volume of Vaxcyte shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 12,340,000 shares of PCVX short. 10.22% of Vaxcyte's shares are currently sold short. Learn More on Vaxcyte's current short interest. What is a good short interest ratio for Vaxcyte? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PCVX shares currently have a short interest ratio of 6.0. Learn More on Vaxcyte's short interest ratio. Which institutional investors are shorting Vaxcyte? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Vaxcyte: Toronto Dominion Bank, Torno Capital LLC, OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC , Group One Trading LLC, Caption Management LLC, Citadel Advisors LLC, Jane Street Group LLC, Boothbay Fund Management LLC, Susquehanna International Group LLP, Concourse Financial Group Securities Inc., JPMorgan Chase & Co., Twin Tree Management LP, and Belvedere Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Vaxcyte? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.22% of Vaxcyte's floating shares are currently sold short. Is Vaxcyte's short interest increasing or decreasing? Vaxcyte saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 12,340,000 shares, an increase of 2.4% from the previous total of 12,050,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Vaxcyte's short interest compare to its competitors? 10.22% of Vaxcyte's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Vaxcyte: Intra-Cellular Therapies, Inc. (2.58%), Genmab A/S (0.33%), Dr. Reddy's Laboratories Limited (1.91%), Moderna, Inc. (16.48%), Ascendis Pharma A/S (11.37%), Viatris Inc. (3.96%), Qiagen (2.11%), Roivant Sciences Ltd. (11.68%), Revolution Medicines, Inc. (10.62%), Lantheus Holdings, Inc. (10.23%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Vaxcyte stock? Short selling PCVX is an investing strategy that aims to generate trading profit from Vaxcyte as its price is falling. PCVX shares are trading up $1.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Vaxcyte? A short squeeze for Vaxcyte occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PCVX, which in turn drives the price of the stock up even further. How often is Vaxcyte's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PCVX, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies ITCI Short Interest GMAB Short Interest RDY Short Interest MRNA Short Interest ASND Short Interest VTRS Short Interest QGEN Short Interest ROIV Short Interest RVMD Short Interest LNTH Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PCVX) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaxcyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaxcyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
